Today: 9 June 2026
IREN stock drops 7% after Monday surge as bitcoin slips; CES chip news in focus
6 January 2026
1 min read

IREN stock drops 7% after Monday surge as bitcoin slips; CES chip news in focus

New York, January 6, 2026, 12:09 EST — Regular session

  • IREN shares slid about 7% in midday trading after a 13% jump on Monday
  • Bitcoin eased about 1%, weighing on U.S.-listed crypto miners
  • Investors are watching CES headlines and IREN’s expected Feb. 11 earnings date

Shares of IREN Ltd fell about 7% in midday Nasdaq trading on Tuesday, pulling back from a sharp prior-session rally as bitcoin eased. The stock was down 7.2% at $44.75, while bitcoin traded around $92,676 and peers Marathon Digital, Riot Platforms and CleanSpark slipped 2% to 5%.

The decline comes a day after IREN jumped 13% to close at $48.24 on roughly 46 million shares, highlighting the stock’s outsized swings early in 2026. For investors, the move matters because IREN sits between two fast-moving themes — crypto-linked mining and AI data-center demand — that can turn on a headline.

Attention has shifted to CES 2026, the annual consumer-electronics event running Jan. 6-9 in Las Vegas, where chip and cloud firms set the tone for AI infrastructure spending. Nvidia on Tuesday introduced its Vera Rubin computing platform, which it said will start rolling out through partners in the second half of 2026.

IREN has been pitching itself as an AI cloud and data-center operator alongside its bitcoin mining business. Microsoft signed a $9.7 billion, five-year agreement with IREN in November to access Nvidia systems hosted at IREN’s Childress, Texas campus, with Dell supplying about $5.8 billion of chips and equipment, Reuters reported.

A Zacks note published on Nasdaq.com on Monday said IREN aims to expand its GPU fleet to about 140,000 units by end-2026 from roughly 23,000 today, targeting $3.4 billion in AI Cloud annualized run-rate revenue, or ARR — a metric that annualises current contracted revenue. Subhasish Mukherjee at Zacks wrote that IREN’s vertically integrated model “enables faster commissioning” of new capacity. Nasdaq

But the stock still trades with bitcoin, and sharp moves in the token can quickly reprice miners’ cash-flow expectations. Execution is also a live risk: delays in power, networking or chip deliveries can push out high-margin AI workloads and test investor patience.

For now, Tuesday’s slide left IREN trying to hold the $44-$45 area after failing to sustain levels near Monday’s close. TradingView data show the shares peaked at $76.87 on Nov. 5, 2025, underscoring how quickly sentiment can swing in the name.

The next set piece is earnings. Zacks expects IREN to report quarterly results on Feb. 11, when investors will look for updates on GPU deployments, customer timing and how quickly AI revenue is scaling relative to bitcoin mining.

Until then, traders will be watching bitcoin’s next move and CES headlines through Jan. 9, with IREN’s volatility likely to remain elevated heading into the February results window.

Stock Market Today

  • Factorial Energy Shares Surge After Nasdaq Ticker Change from Cartesian Growth
    June 9, 2026, 9:18 AM EDT. Factorial Energy (ticker FAC) began trading on Nasdaq after merging with Cartesian Growth Corporation III (CGCT), marking the SPAC's transition from a shell company to an operating battery tech firm. Shares surged 16% to $13.80 on June 8, with premarket quotes near $20.70 the next day. The merger valued Factorial at approximately $1.3 billion and raised over $100 million to support commercializing solid-state batteries, which offer improved range and safety over traditional lithium-ion cells. CEO Siyu Huang emphasized the listing will accelerate the company's development. Factorial focuses on validation milestones, with partnerships including Mercedes-Benz and Stellantis. The move positions Factorial alongside public battery tech firms like QuantumScape and Solid Power, amid investor reshuffling following the transaction.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Uber stock hit by Melius “Sell” call as robotaxi threat sharpens; Wolfe sets $110 target
Previous Story

Uber stock hit by Melius “Sell” call as robotaxi threat sharpens; Wolfe sets $110 target

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure
Next Story

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Go toTop